Vinberg laboratory collaborates with a spin-off company Eyescreen, Inc. to establish and use human donor eye platform as a Novel Approach Methodology (NAM) for preclinical drug testing. This work is funded by NIH/NEI SBIR grant as well as revenue generated by Eyescreen, Inc., a startup company that operates at the Altitude Lab, a healthcare accelerater located in Salt Lake City, Utah. This work was recently featured in a story from the Technology Licensing office at the University of Utah. Related work involve resolving mechanisms of ischemic inury in the retina